This HTML5 document contains 156 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n12http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38817006
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ tudományos cikk 2017年论文 научни чланак 2017年論文 научни чланак artigo científico scienca artikolo scientific article published on 27 April 2017 articol științific tieteellinen artikkeli 2017年论文 vědecký článek 2017年論文 artikel ilmiah artigo científico 2017年論文 artykuł naukowy vitenskapelig artikkel artikull shkencor 2017년 논문 naučni članak 2017年論文 научна статия ২৭ এপ্রিল ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico articolo scientifico სამეცნიერო სტატია 2017年论文 article scientific 2017 nî lūn-bûn teaduslik artikkel article científic vedecký článok artículu científicu espublizáu en 2017 vitskapeleg artikkel 2017年论文 наукова стаття, опублікована у квітні 2017 wetenschappelijk artikel επιστημονικό άρθρο מאמר מדעי article scientifique artikulong pang-agham bilimsel makale scientific article published on 27 April 2017 bài báo khoa học научная статья 2017年论文 2017年論文 vetenskaplig artikel artículo científico publicado en 2017 videnskabelig artikel مقالة علمية نشرت في 27 أبريل 2017 บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel 2017年论文 2017年の論文 scientific article published on 27 April 2017
p:P577
wds:Q38817006-E11FA35A-758F-4DCD-84B0-7FEC411D252B
wdt:P577
2017-06-01T00:00:00Z
p:P407
wds:Q38817006-5215F1F6-CFBD-41F0-B6B5-D72FDEBDFB60
wdt:P407
wd:Q1860
p:P2860
wds:Q38817006-53870E5F-4E17-41B7-ACBD-8616D9173089 wds:Q38817006-640A32D2-D791-47A6-BE9F-DD2FE491D83C wds:Q38817006-79D17B15-FBA8-4332-A00C-346EE922E496 wds:Q38817006-7AB70BCF-8BA5-4EE9-B49B-169E43270108 wds:Q38817006-7D609F7C-0051-4537-BC2F-9255136CB32E wds:Q38817006-88F5A5E1-0F53-4F8F-82EC-7F13587DD9D2 wds:Q38817006-47D1646F-81F9-423F-B45F-6D191949F30E wds:Q38817006-4E468F3C-1516-42AD-97AD-A6107FF90DB9 wds:Q38817006-D160E17F-2B80-4779-AF4A-7376F47EAD7C wds:Q38817006-E4394F74-EF87-4769-9DCB-E11EAD5C3B52 wds:Q38817006-F8E4D462-2277-4225-928A-AE64C4E491A1 wds:Q38817006-A88624C1-FCB9-47A3-A7E3-8936E8CB9E3F wds:Q38817006-0CFB220A-A13D-4D58-BEB6-112B8905865E wds:Q38817006-10A08F06-5D47-4510-ABA4-7C7B90F5E06B wds:Q38817006-10F34C9E-6E26-44D1-8972-8D8BF509B42F wds:Q38817006-121E9063-46A7-4908-A0C1-4071DBAB55C8 wds:Q38817006-1F4468E1-322E-4E1F-9FC4-2918780CD8A5 wds:Q38817006-0CCCB117-6BF8-45AD-9583-A63FEC67CC47
wdt:P2860
wd:Q28300546 wd:Q70215925 wd:Q57767905 wd:Q33860909 wd:Q35575496 wd:Q34227470 wd:Q33843242 wd:Q33567438 wd:Q35704462 wd:Q34170485 wd:Q33860902 wd:Q36155647 wd:Q35943499 wd:Q34410765 wd:Q35205053 wd:Q34740245 wd:Q35902351 wd:Q34157994
p:P2093
wds:Q38817006-24BF91D6-E348-43CA-A005-9A2D9C91405B wds:Q38817006-BC663A3E-F9C6-4632-BB4A-FA800AE51634 wds:Q38817006-A664BFA5-7B57-4582-9A6A-ACAEE3A62E7F wds:Q38817006-9DD9E456-7AD6-4D9A-A412-4E78DE559B94 wds:Q38817006-94C190A2-304B-4085-A3FC-F8CC1B084336 wds:Q38817006-97C38A8A-F610-47B7-9E4A-71A7FE35591E wds:Q38817006-915B57B5-101E-494F-97F5-38115F2048AB
wdt:P2093
John A Wells Harinderjit Singh Alessandro A Castellarin Paul L Kaufman Danni Liu Michele Melia Barbara A Blodi
rdfs:label
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
skos:prefLabel
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
schema:name
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
p:P50
wds:Q38817006-3FE7707B-58E4-4522-BCA2-EDF49FC6D0D3 wds:Q38817006-411106A8-4EE5-482D-82D0-C0CC80C092B7 wds:Q38817006-06C426F9-0B71-49D5-9F21-5114020472C8 wds:Q38817006-176BF17D-C55F-45F7-955E-A3ADB7D3EFF7
wdt:P50
wd:Q111076721 wd:Q114739669 wd:Q98806904 wd:Q98807054
p:P1476
wds:Q38817006-3BC959C6-9D55-4A2F-AAB1-8FF72EA24ADB
wdt:P1476
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
p:P304
wds:Q38817006-DF7ECDD0-029A-4B5A-B9B4-E8834FD25218
wdt:P304
558-568
p:P31
wds:Q38817006-D09AFA9A-7066-47B8-ACD7-DC6B7D02AB42
wdt:P31
wd:Q13442814
p:P921
wds:Q38817006-B2D19C87-D5DD-4C55-89B5-CAC840CD2A06 wds:Q38817006-1A5F796F-1504-405A-A861-7DFB88BA885A wds:Q38817006-4D651552-18C2-4414-96AB-AD558CC19000
wdt:P921
wd:Q4689286 wd:Q413299 wd:Q631361
p:P698
wds:Q38817006-051AD1CD-B812-4DF0-8123-81A32D94A862
wdtn:P698
n9:28448655
wdt:P698
28448655
p:P1433
wds:Q38817006-8419F2A2-6C89-4E3A-8D87-978079406105
wdt:P1433
wd:Q4787301
p:P433
wds:Q38817006-B506940F-F7A8-434D-8622-3D56F3C08C6A
p:P478
wds:Q38817006-015B42A2-7740-4720-AFAD-6A2C22EA0CBD
wdt:P433
6
wdt:P478
135
p:P356
wds:Q38817006-46F6ED06-6089-42F4-BD80-D866232C88C8
wdtn:P356
n12:JAMAOPHTHALMOL.2017.0821
wdt:P356
10.1001/JAMAOPHTHALMOL.2017.0821
p:P932
wds:Q38817006-99AAD917-1BB8-47CE-89DE-7C3C2A96E0FF
wdt:P932
5540030